chr21-46120507-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001849.4(COL6A2):c.1333-8T>C variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.214 in 1,512,874 control chromosomes in the GnomAD database, including 37,201 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001849.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.1333-8T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000300527.9 | NP_001840.3 | |||
COL6A2 | NM_058174.3 | c.1333-8T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000397763.6 | NP_478054.2 | |||
COL6A2 | NM_058175.3 | c.1333-8T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_478055.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.1333-8T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001849.4 | ENSP00000300527 | P1 | |||
COL6A2 | ENST00000397763.6 | c.1333-8T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 5 | NM_058174.3 | ENSP00000380870 | ||||
COL6A2 | ENST00000409416.6 | c.1333-8T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 5 | ENSP00000387115 |
Frequencies
GnomAD3 genomes AF: 0.179 AC: 27138AN: 151980Hom.: 2759 Cov.: 34
GnomAD3 exomes AF: 0.179 AC: 20432AN: 114234Hom.: 2088 AF XY: 0.181 AC XY: 11094AN XY: 61272
GnomAD4 exome AF: 0.217 AC: 295954AN: 1360774Hom.: 34441 Cov.: 32 AF XY: 0.216 AC XY: 144602AN XY: 670540
GnomAD4 genome AF: 0.178 AC: 27144AN: 152100Hom.: 2760 Cov.: 34 AF XY: 0.173 AC XY: 12849AN XY: 74364
ClinVar
Submissions by phenotype
not specified Benign:6
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 28, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 07, 2016 | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 15, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 19, 2016 | - - |
Myosclerosis Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Collagen 6-related myopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Bethlem myopathy 1A Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at